Skip to main content
NETEC logo - link to main NETEC page

Clinical Guidance

Clinical Guidance

This page contains documents, including webinars, flyers, and publications, with Clinical Care guidance for health care professionals.  See below for documents on the following subjects:

General Clinical Guidance:

Microvascular Injury in the Brains of Patients with Covid-19

Microvascular Injury in the Brains of Patients with Covid-19

COVID-19 Testing 101

COVID-19 Testing 101

NIH COVID-19 Treatment Guidelines

NIH COVID-19 Treatment Guidelines

Code Blue for a Pandemic Situation

Code Blue for a Pandemic Situation

Transport of a Proned/Intubated Patient

Transport of a Proned/Intubated Patient

COVID-19 Surgical Safety Best Practices and Innovations

COVID-19 Surgical Safety Best Practices and Innovations

Minimizing Surgical Room Contamination

Minimizing Surgical Room Contamination

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

NETEC COVID-19 Webinar Series (11/20/20)/Online Course: Pandemic Related Consent, Research and Ethics

Pandemic Related Consent, Research and Ethics

Renal Replacement Therapy in Patients with COVID-19: Increased Need for Renal Replacement Therapy (RRT)

Renal Replacement Therapy in Patients with COVID-19

NETEC COVID-19 Webinar Series (11/06/20)/Online Course: Care Transitions to Home Health: Key COVID-19 Considerations

Care Transitions to Home Health: Key COVID-19 Considerations (November 6, 2020)

NETEC COVID-19 Webinar Series (11/04/20)/Online Course: COVID-19 and Acute Renal Failure

COVID-19 and Acute Renal Failure (November 4, 2020)

Pathophysiology of COVID-19

Pathophysiology of COVID-19

Respiratory Support Strategies

Respiratory Support Strategies

COVID-19 Considerations for Labor & Delivery Patients

COVID-19 Considerations for Labor & Delivery Patients

Telemedicine Flyer

Telemedicine Flyer

NETEC COVID-19 Webinar Series (5/1/20)/Online Course: The Use of Proning: Implications for your Patients and Your Team

The Use of Proning: Implications for your Patients and Your Team

Tips for Assembling, Testing, and Running Proning Teams

Tips for Assembling, Testing, and Running Proning Teams

Managing ICU surge during the COVID-19 crisis: Rapid Guidelines

Managing ICU surge during the COVID-19 crisis: Rapid Guidelines

Kawasaki-like disease: emerging complication during the COVID-19 pandemic

Kawasaki-like disease: emerging complication during the COVID-19 pandemic

COVID-19 Symptoms

COVID-19 Symptoms

1-Check COVID

1-Check COVID

NETEC: COVID-19 Laboratory Specimen Collection: Nasopharyngeal Swab - Flyer and Validation Checklist

NETEC: COVID-19 Laboratory Specimen Collection: Nasopharyngeal Swab - Flyer

NETEC: COVID-19 Laboratory Specimen Collection: Nasopharyngeal Swab - Flyer and Validation Checklist

NETEC: COVID-19 Laboratory Specimen Collection: Nasopharyngeal Swab - Validation Checklist

NETEC: COVID-19 Laboratory Specimen Collection: Nasopharyngeal Swab

NETEC: COVID-19 Laboratory Specimen Collection: Nasopharyngeal Swab - Video

COVID-19: combining antiviral and anti-inflammatory treatments

COVID-19: combining antiviral and anti-inflammatory treatments

Radiologists Describe Coronavirus Imaging Features

Radiologists Describe Coronavirus Imaging Features

Therapeutics:

Monoclonal Antibody Therapy

Monoclonal Antibody Therapy

NETEC COVID-19 Webinar Series (11/25/20)/Online Course: Monoclonal Antibody Therapeutics: How to Operationalize mAB Therapy at Your Facility

Monoclonal Antibody Therapeutics: How to Operationalize mAB Therapy at Your Facility (November 25, 2020)

NETEC COVID-19 Webinar Series (11/25/20)/Online Course: Monoclonal Antibody Therapeutics: How to Operationalize mAB Therapy at Your Facility

Monoclonal Antibody Therapeutics: Bamlanivimab Therapy Plan

NETEC COVID-19 Webinar Series (11/18/20)/Online Course: COVID-19 Therapeutics

COVID-19 Therapeutics

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of CASIRIVIMAB and IMDEVIMAB

Fact Sheet for Health Care Providers: EUA of CASIRIVIMAB and IMDEVIMAB

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of BARICITINIB

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of BARICITINIB

Fact Sheet for Heath Care Providers: Emergency Use Authorization (EUA) of Bamlanivimab

Fact Sheet for Heath Care Providers: Emergency Use Authorization (EUA) of Bamlanivimab

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of COVID-19 Convalescent Plasma for Treatment of COVID-19 in Hospitalized Patients

Fact Sheet for Health Care Providers: EUA of COVID-19 Convalescent Plasma

Fact Sheet for Healthcare Providers: REGIOCIT (Sodium Chloride and Sodium Citrate Renal Replacement and Regional Anticoagulant solution)

Fact Sheet for Health Care Providers: EUA of REGIOCIT (Sodium Chloride and Sodium Citrate Renal Replacement and Regional Anticoagulant solution)

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of FRESENIUS PROPOVEN 2% Emulsion

Fact Sheet for Health Care Providers: EUA of FRESENIUS PROPOVEN 2% Emulsion

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of VEKLURY® (remdesivir) for Hospitalized Pediatric Patients weighing 3.5 kg to less than 40 kg OR Hospitalized Pediatric Patients less than 12 years of age weighing at least 3.5 kg.

Fact Sheet for Health Care Providers: EUA of VEKLURY® (remdesivir) for Hospitalized Pediatric Patients...

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of multiFiltrate PRO System and multiBic/multiPlus Solutions during the COVID-19 Pandemic

Fact Sheet for Health Care Providers: EUA of multiFiltrate PRO System and multiBic/multiPlus Solutions during the COVID-19 Pandemic

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY)

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Remdesivir for the Treatment of Covid-19 — Final Report

Remdesivir for the Treatment of Covid-19 — Final Report

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lopinavir–ritonavir in patients admitted to hospital with COVID-19

Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial

Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

The RECOVERY Platform

The RECOVERY Platform

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Appropriate selection of convalescent plasma donors for COVID-19

Appropriate selection of convalescent plasma donors for COVID-19

Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19

Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19

Remdesivir for the Treatment of Covid-19 — Preliminary Report

Remdesivir for the Treatment of Covid-19 — Preliminary Report

The Use of Convalescent Plasma Therapy and Remdesivir in the Successful Management of a Critically Ill Obstetric Patient With Novel Coronavirus 2019 Infection: A Case Report

Convalescent Plasma Therapy and Remdesivir in the Successful Management of a Critically Ill Obstetric Patient

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Convalescent plasma as a potential therapy for COVID-19

Convalescent plasma as a potential therapy for COVID-19

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

Case Studies:

Case 40-2020: A 24-Year-Old Man with Headache and Covid-19

Case 40-2020: A 24-Year-Old Man with Headache and Covid-19

Covid-19–Associated Myopathy Caused by Type I Interferonopathy

Covid-19–Associated Myopathy Caused by Type I Interferonopathy

Genomic evidence for reinfection with SARS-CoV-2: a case study

Genomic evidence for reinfection with SARS-CoV-2: a case study

Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation

A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation

Case 26-2020: A 60-Year-Old Woman with Altered Mental Status and Weakness on the Left Side

A 60-Year-Old Woman with Altered Mental Status and Weakness on the Left Side

SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report

SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report

Case 25-2020: A 47-Year-Old Woman with a Lung Mass

A 47-Year-Old Woman with a Lung Mass

Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series

Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series

Case 24-2020: A 44-Year-Old Woman with Chest Pain, Dyspnea, and Shock

A 44-Year-Old Woman with Chest Pain, Dyspnea, and Shock

Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study

Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19

NETEC COVID-19 Webinar Series (7/24/20)/Online Course: Surgical Cases and Considerations for COVID-19 Patients: Part 2

Surgical Cases and Considerations for COVID-19 Patients: Part 2

NETEC COVID-19 Webinar Series (7/17/20)/Online Course: Surgical Cases and Considerations: Part 1

Surgical Cases and Considerations: Part 1

An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19

An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19

Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19

A 76-Year-Old Woman Who Died from Covid-19

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic

A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic

Case 21-2020: A 66-Year-Old Homeless Man with Covid-19

A 66-Year-Old Homeless Man with Covid-19

SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series

SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship

Case 18-2020: A 73-Year-Old Man with Hypoxemic Respiratory Failure and Cardiac Dysfunction

A 73-Year-Old Man with Hypoxemic Respiratory Failure and Cardiac Dysfunction

Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study

Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy

Case 19-2020: A 74-Year-Old Man with Acute Respiratory Failure and Unclear Goals of Care

A 74-Year-Old Man with Acute Respiratory Failure and Unclear Goals of Care

Covid-19 in Critically Ill Patients in the Seattle Region — Case Series

Covid-19 in Critically Ill Patients in the Seattle Region

The Use of Convalescent Plasma Therapy and Remdesivir in the Successful Management of a Critically Ill Obstetric Patient With Novel Coronavirus 2019 Infection: A Case Report

Convalescent Plasma Therapy and Remdesivir in the Successful Management of a Critically Ill Obstetric Patient With Novel Coronavirus 2019 Infection

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury

A 68-Year-Old Man with Covid-19 and Acute Kidney Injury

Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy: A Case Report.

Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York

Clinical Characteristics of Covid-19 in New York City

Clinical Characteristics of Covid-19 in New York City

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

Clinical Guidance

Share this page: